Researchers have used CRISPR technology to identify potential antidotes for various venomous substances, including box jellyfish venom, deadly mushroom poison, and snake venom. The discoveries suggest that common substances, such as blood thinners, may be effective in treating certain types of envenoming. However, the specific applications and targets of the CRISPR-based antidotes appear to vary, with different outlets reporting different types of venom and corresponding treatments.